| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), AKBA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.46M | $3.15M | - | |
| CFO | 707.6K | $643.8K | - | |
| VP | 348.9K | $317.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2021 | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 1,060 | $3.40 | $3,604.00 | -0.4% | +13.8% | -79.9% | |
| Apr 1, 2021 | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 1,211 | $3.40 | $4,117.40 | -0.5% | +13.8% | -79.9% | |
| Apr 1, 2021 | Butler John P.61 | CEO And President | Sell | 4,109 | $3.40 | $13,970.60 | -0.4% | +13.8% | -79.9% | |
| Apr 1, 2021 | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 1,081 | $3.40 | $3,675.40 | -0.6% | +13.8% | -79.9% | |
| Mar 1, 2021 | Butler John P.61 | CEO And President | Sell | 49,990 | $3.40 | $169,771.04 | -2.2% | +1.3% | -36.1% | |
| Mar 1, 2021 | Faulkingham Dell70 | CCO | Sell | 6,749 | $3.40 | $22,920.28 | -5.0% | +1.3% | -36.1% | |
| Mar 1, 2021 | Hadas Nicole R.60 | SVP, Chief Legal Officer | Sell | 14,285 | $3.40 | $48,513.29 | -2.6% | +1.3% | -36.1% | |
| Mar 1, 2021 | Dahan Michel59 | SVP, Chief Operating Officer | Sell | 14,547 | $3.40 | $49,403.07 | -2.7% | +1.3% | -36.1% | |
| Mar 1, 2021 | Burke Steven Keith61 | SVP, Chief Medical Officer | Sell | 7,558 | $3.40 | $25,667.72 | -4.5% | +1.3% | -36.1% | |
| Jun 8, 2020 | Gowen Maxine | Director | Sell | 4,567 | $12.05 | $55,032.35 | -15.9% | - | - |